Atossa Genetics receives CE Mark for the ForeCYTE breast aspirator device
Atossa Genetics announced it has received certification to Annex II of the European Medical Device Directive from its European Notified Body, DQS Medizinprodukte, which allows Atossa to place the "CE" Mark on the ForeCYTE Breast Aspirator for distribution in the EU and its member states. October 22, 2014